Chemomab Therapeutics Ltd. (CMMB) stock
Close on Nov 13, 2026Market cap $11.00MP/E 1.1Yield –
Chemomab Therapeutics statistics
69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.27
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 42.1%
- 10.8%
- Float
- 418M
- 49M
- Shares Held by Insiders
- 27.4%
- 11.7%
- Shares Held by Institutions
- 0.07%
- 56.4%
Short sellingIndustry
- Short Interest
- 5,139
- –
- Short Interest Change
- -63.0%
- -0.80%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $2.99
- –
- 52-Week Low
- $0.92
- –
- 20-Day Moving Average
- $1.21
- –
- 50-Day Moving Average
- $1.65
- –
- 200-Day Moving Average
- $1.74
- –
- Average True Range (14)
- $0.15
- –
- Price Change (1 Week)
- 15.9%
- -1.15%
- Price Change (1 Month)
- 18.6%
- -4.87%
- Price Change (3 Months)
- -20.3%
- -21.0%
- Price Change (6 Months)
- -7.83%
- -20.6%
- Price Change (YTD)
- -7.27%
- -23.6%
- Price Change (1 Year)
- -42.9%
- -22.4%
- Price Change (3 Years)
- -37.3%
- -29.5%
- Price Change (5 Years)
- -96.1%
- -77.9%
- Average Volume (10 Days)
- 70,565
- –
- Average Volume (20 Days)
- 61,868
- –
- Average Volume (90 Days)
- 96,124
- –
- Relative Volume
- 0.86
- 0.70
- Relative Strength Index (14)
- 62.8
- 43.4
- Volatility (1 Year)
- 95.5%
- 80.1%
- Beta (5 Years)
- 1.47
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -97.9%
- -49.9%
- Return on Assets (ROA)
- -84.2%
- -40.6%
- Return on Invested Capital (ROIC)
- -8102.6%
- -32.9%
- Return on Capital Employed (ROCE)
- -1289.6%
- -37.9%
Financial positionIndustry
- Current Ratio
- 6.41
- 3.30
- Quick Ratio
- 4.31
- 2.39
GrowthIndustry
- EPS Growth (YoY)
- -53.8%
- -12.3%
- EPS Growth (3Y CAGR)
- -47.0%
- 1.30%
- EPS Growth (5Y CAGR)
- -16.4%
- 3.78%
EfficiencyIndustry
- Profits Per Employee
- -$899.50K
- -$689.41K
- Employee Count
- 10
- 74
- WACC
- 12.4%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$9.00M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $6.70M
- $17.76M
- Net Cash Per Share
- $0.01
- $0.80
- Equity (Book Value)
- $8.69M
- $53.89M
- Book Value Per Share
- $0.02
- $1.50
- Tangible Book Value
- $8.69M
- $27.13M
- Working Capital
- $8.40M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$3.00K
- -$1.00M
- FCF Per Share
- -$0.02
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -81.7%
- -21.8%
- FCF Yield
- -101.2%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $0
- $73.00K
Scores and fair valueIndustry
- Graham Number
- $0.08
- $19.34
- Graham Upside
- 308.8%
- -46.6%
- Altman Z-Score
- -46.67
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CMMB | S&P 500 | Difference | CMMB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +23.4% | -3.0% | +26.4 pts | ||
| 3 months | -19.5% | -2.8% | −16.7 pts | ||
| Year to date | -7.3% | +11.5% | −18.8 pts | ||
| 1 year | -40.0% | +13.5% | −53.5 pts | ||
| 3 years | -30.5% | +77.7% | −108.2 pts | -11.4% | +21.1% |
| 5 years | -96.1% | +72.6% | −168.7 pts | -47.6% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M CMMB shares were sold short on Oct 30, 2026, down 63.0% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 21.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,139 | -63.0% | 48,290 | 1.0 |
| Oct 15, 2026 | 13,889 | +31.7% | 43,029 | 1.0 |
| Sep 30, 2026 | 10,544 | -87.1% | 215,472 | 1.0 |
| Sep 15, 2026 | 81,947 | -20.2% | 83,213 | 1.0 |
| Aug 31, 2026 | 102,705 | -9.2% | 139,834 | 1.0 |
| Aug 14, 2026 | 113,157 | -27.3% | 58,882 | 1.9 |
| Jul 31, 2026 | 155,604 | +15.3% | 71,908 | 2.2 |
| Jul 15, 2026 | 134,909 | -5.8% | 506,716 | 1.0 |
| Jun 30, 2026 | 143,144 | +6.6% | 34,378 | 4.2 |
| Jun 15, 2026 | 134,275 | +247.4% | 49,633 | 2.7 |
| May 29, 2026 | 38,648 | -2.5% | 50,866 | 1.0 |
| May 15, 2026 | 39,649 | -16.3% | 45,269 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?